ArticleInternational journal of molecular sciences2026
Intrafollicular PAI-1 Expression Is Associated with Absence of Histological Transformation During Long-Term Follow-Up in Follicular Lymphoma.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Follicular lymphoma (FL) is an indolent B-cell malignancy typically associated with favourable outcomes and prolonged survival. However, histological transformation (HT) occurs in a subset of patients and significantly worsens survival outcomes, markedly altering the disease course. Currently, no clinical or molecular predictors of HT are available. We sought to evaluate the potential of Serpin family E member 1 (PAI-1) as a prognostic biomarker of HT in FL, with expression levels assessed by immunohistochemistry and quantified using digital image analysis. PAI-1 expression was evaluated in diagnostic lymphoma biopsies from 30 FL patients with no record of subsequent HT with a minimum follow-up of 10 years, ranging from 10.1 to 24.8 years (non-transforming FL, nt-FL), and 18 patients with subsequent HT occurring 0.7 to 14.6 years after diagnosis (subsequently transforming FL, st-FL); furthermore, the paired high-grade biopsy from the time of HT (transformed FL, tFL) was included. No significant differential expression patterns were identified comparing nt-FL, st-FL and tFL samples. However, high intrafollicular PAI-1 expression at FL diagnosis correlated with no transformation events observed. We believe high intrafollicular PAI-1 expression at presentation might define a minor subgroup of FL patients with reduced risk of HT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.